- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in antibody engineering for rheumatic diseases
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 15, Issue 4, Pages 197-207
Publisher
Springer Nature
Online
2019-02-27
DOI
10.1038/s41584-019-0188-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells
- (2018) Philip E. Brandish et al. BIOCONJUGATE CHEMISTRY
- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Market watch: Top drugs and companies by sales in 2017
- (2018) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Therapy: Arming the regulators — new strategies to treat autoimmunity
- (2018) Richard O. Williams et al. Nature Reviews Rheumatology
- Bispecific antibodies for cancer therapy: A review
- (2018) Anuradha Krishnamurthy et al. PHARMACOLOGY & THERAPEUTICS
- Bispecific antibodies: design, therapy, perspectives
- (2018) Sergey Sedykh et al. Drug Design Development and Therapy
- Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis
- (2018) Roman Fischer et al. Arthritis & Rheumatology
- Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
- (2018) Sujuan Yang et al. Frontiers in Immunology
- Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
- (2018) Cornelia Hutmacher et al. ADVANCED DRUG DELIVERY REVIEWS
- A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo
- (2017) Alberto Dal Corso et al. JOURNAL OF CONTROLLED RELEASE
- Axial spondyloarthritis
- (2017) Joachim Sieper et al. LANCET
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy
- (2017) Roberto De Luca et al. MOLECULAR CANCER THERAPEUTICS
- Bispecific antibody pipeline moves beyond oncology
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Affibody Molecules in Biotechnological and Medical Applications
- (2017) Stefan Ståhl et al. TRENDS IN BIOTECHNOLOGY
- Antibody–Drug Conjugates for the Treatment of Inflammation
- (2017) Gerard Rosse ACS Medicinal Chemistry Letters
- Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors
- (2017) Katerina T. Xenaki et al. Frontiers in Immunology
- Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
- (2017) Peter Bannas et al. Frontiers in Immunology
- Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions
- (2016) Kyla R. Rodgers et al. BIOTECHNOLOGY ADVANCES
- Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation
- (2016) Søren B. van Witteloostuijn et al. ChemMedChem
- Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions
- (2016) Franziska Bootz et al. DRUG DISCOVERY TODAY
- Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation
- (2016) Janine Woytschak et al. IMMUNITY
- Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site
- (2016) Jonathan D. Kiefer et al. IMMUNOLOGICAL REVIEWS
- Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate
- (2016) Shan Yu et al. MOLECULAR THERAPY
- Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
- (2015) Jennifer Dumont et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Bispecific antibodies
- (2015) Roland E. Kontermann et al. DRUG DISCOVERY TODAY
- Alternatively Spliced EDA Domain of Fibronectin Is a Target for Pharmacodelivery Applications in Inflammatory Bowel Disease
- (2015) Franziska Bootz et al. INFLAMMATORY BOWEL DISEASES
- An Immunosuppressive Antibody–Drug Conjugate
- (2015) Rongsheng E. Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases
- (2015) Michela Silacci et al. mAbs
- Targeting FcRn for the modulation of antibody dynamics
- (2015) E. Sally Ward et al. MOLECULAR IMMUNOLOGY
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
- (2015) Sophie M. Lehar et al. NATURE
- Global epidemiology of gout: prevalence, incidence and risk factors
- (2015) Chang-Fu Kuo et al. Nature Reviews Rheumatology
- The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model
- (2015) Federica Quattrone et al. Reproductive Sciences
- Tregs activated by bispecific antibodies
- (2015) Stefanie Koristka et al. OncoImmunology
- Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation
- (2014) Teresa Hemmerle et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis
- (2014) T. Hemmerle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Recent advances in mammalian protein production
- (2013) Ashok D. Bandaranayake et al. FEBS LETTERS
- Nanobodies and their potential applications
- (2013) Gholamreza Hassanzadeh-Ghassabeh et al. Nanomedicine
- Polyethyleneimine-based transient gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells
- (2013) David L. Hacker et al. PROTEIN EXPRESSION AND PURIFICATION
- The Economic Costs of Pain in the United States
- (2012) Darrell J. Gaskin et al. JOURNAL OF PAIN
- Dual targeting strategies with bispecific antibodies
- (2012) Roland Kontermann mAbs
- Non-immunoglobulin based protein scaffolds
- (2011) John Löfblom et al. CURRENT OPINION IN BIOTECHNOLOGY
- The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
- (2011) Kathrin Schwager et al. HUMAN REPRODUCTION
- Retargeting of Human Regulatory T Cells by Single-Chain Bispecific Antibodies
- (2011) S. Koristka et al. JOURNAL OF IMMUNOLOGY
- Buy buy bispecific antibodies
- (2011) David Holmes NATURE REVIEWS DRUG DISCOVERY
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor subunit CD25
- (2010) S. Letourneau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered protein scaffolds as next-generation antibody therapeutics
- (2009) Michaela Gebauer et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
- (2009) Andrea Rubbert-Roth et al. ARTHRITIS RESEARCH & THERAPY
- Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
- (2009) Kathrin Schwager et al. ARTHRITIS RESEARCH & THERAPY
- Erratum: Addendum: Protein production and purification
- (2008) et al. NATURE METHODS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started